Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Corteva (CTVA) Research & Development (2018 - 2025)

Corteva has reported Research & Development over the past 8 years, most recently at $413.0 million for Q4 2025.

  • Quarterly results put Research & Development at $413.0 million for Q4 2025, up 13.15% from a year ago — trailing twelve months through Dec 2025 was $1.5 billion (up 5.14% YoY), and the annual figure for FY2025 was $1.5 billion, up 5.14%.
  • Research & Development for Q4 2025 was $413.0 million at Corteva, up from $351.0 million in the prior quarter.
  • Over the last five years, Research & Development for CTVA hit a ceiling of $413.0 million in Q4 2025 and a floor of $268.0 million in Q1 2022.
  • Median Research & Development over the past 5 years was $333.5 million (2023), compared with a mean of $330.8 million.
  • Biggest five-year swings in Research & Development: dropped 4.63% in 2022 and later increased 17.91% in 2023.
  • Corteva's Research & Development stood at $316.0 million in 2021, then increased by 7.59% to $340.0 million in 2022, then rose by 5.0% to $357.0 million in 2023, then rose by 2.24% to $365.0 million in 2024, then increased by 13.15% to $413.0 million in 2025.
  • The last three reported values for Research & Development were $413.0 million (Q4 2025), $351.0 million (Q3 2025), and $375.0 million (Q2 2025) per Business Quant data.